ABSTRACT
Objective To observe the clinical efficacy of herb-partitioned moxibustion (HPM) for constipation-predominant irritable bowel syndrome (C-IBS) from the perspective of regulating liver. Method Forty C-IBS patients were randomized into a HPM group and a Western medication group. The HPM group was intervened by HPM from the perspective of regulating liver, while the Western medication group was by lactulose, both for 4 weeks. The clinical efficacies were then compared between the two groups. Result In the HPM group, 13 subjects were recovered, 3 showed markedly effective, 1 showed effective, and 3 failed; in the Western medication group, 7 subjects were cured, 3 showed markedly effective, 2 showed effective, and 8 failed. The therapeutic efficacy of the HPM group was significantly superior to that of the Western medication group (P<0.01). Conclusion HPM by regulating liver can produce a significant clinical efficacy in treating C-IBS.